DrugPatentWatch Database Preview

Details for Patent: 7,832,351

« Back to Dashboard

Which drugs does patent 7,832,351 protect, and when does it expire?

Patent 7,832,351 protects ADVAIR HFA, FLOVENT HFA, and VENTOLIN HFA, and is included in three NDAs.

Protection for ADVAIR HFA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-eight patent family members in seventeen countries.

Summary for Patent: 7,832,351

Title:	Actuation indicator for a dispensing device
Abstract:	An actuation indicator which includes a drums sub-assembly including a rotatable actuation indicator wheel, a rocking ratchet pawl for rotating the indicator wheel in a set direction and a rocking mechanism for the pawl driven by a slipping clutch arrangement, wherein the slipping clutch arrangement includes a slipping clutch spring engaged at one end to a pinion of a rack and pinion assembly and at a second end to the ratchet pawl is described.
Inventor(s):	Bonney; Stanley George (Ware, GB), Brand; Peter John (Ware, GB), Godfrey; James William (Ware, GB), Rand; Paul Kenneth (Ware, GB)
Assignee:	Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:	12/333,420
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,832,351
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,832,351
Patent Claim Types: see list of patent claims	Device; Delivery;

Drugs Protected by US Patent 7,832,351

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED;INHALATION	021254-001	Jun 8, 2006		RX	Yes	Yes					Y
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED;INHALATION	021254-002	Jun 8, 2006		RX	Yes	Yes					Y
Glaxo Grp Ltd	ADVAIR HFA	fluticasone propionate; salmeterol xinafoate	AEROSOL, METERED;INHALATION	021254-003	Jun 8, 2006		RX	Yes	Yes					Y
Glaxo Grp Ltd	FLOVENT HFA	fluticasone propionate	AEROSOL, METERED;INHALATION	021433-003	May 14, 2004		RX	Yes	Yes					Y
Glaxo Grp Ltd	FLOVENT HFA	fluticasone propionate	AEROSOL, METERED;INHALATION	021433-002	May 14, 2004		RX	Yes	Yes					Y
Glaxo Grp Ltd	FLOVENT HFA	fluticasone propionate	AEROSOL, METERED;INHALATION	021433-001	May 14, 2004		RX	Yes	Yes					Y

International Family Members for US Patent 7,832,351

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	424010
Australia	2003278236
Brazil	0311557
Canada	2489554
China	101853424
China	1662930